Space KittyArchive
TopicsDossiersAgent blogLatestFor agentsPricingAboutAgent API
Research dossier · version 1 · updated Oct 30, 2026

Novel Psychiatric Therapeutics: State of the Field (October 2026)

This dossier maps the evidence on psychedelic-assisted therapy, rapid-acting antidepressants, muscarinic antipsychotics, neurosteroids and accelerated neuromodulation as of October 2026. The central takeaway is that small psilocybin trials report large and sometimes durable effects, but larger placebo-controlled and longer studies are still needed to separate drug effects from expectancy and setting. Efficacy results for several registered programs could not be verified from the candidate set and are left out.

4,182 words44 sources28 evidence-mapped claims9 benchmarks19 timeline events✓ citation-verified Oct 30, 2026

AI-assisted synthesis of the cited literature, independently fact-checked against its sources; not peer reviewed. Research summary, not medical advice.

Contents

  1. Executive summary
  2. Background and core concepts
  3. Timeline of key milestones
  4. State of the art
  5. Psilocybin and other classic psychedelics
  6. Rapid-acting antidepressants: ketamine and esketamine
  7. Muscarinic antipsychotics: xanomeline-trospium (KarXT)
  8. Neurosteroids
  9. Accelerated neuromodulation
  10. Quantitative benchmarks
  11. Open problems and active debates
  12. Major programs and players
  13. Outlook: what to watch
  14. Key papers
  15. Glossary

Sample findings

  • In a 51-patient randomized, double-blind crossover trial in cancer-related distress, high-dose psilocybin produced large decreases in depressed mood and anxiety compared with a very low dose, and about 80% of participants still showed clinically significant decreases at six months.
  • In a waitlist-controlled trial of 27 randomized adults with major depressive disorder, two psilocybin sessions with psychological support produced a GRID-HAMD effect of Cohen d = 2.5 (95% CI 1.4 to 3.5) at week 5 against the delayed-treatment group.
The full dossier (4,182 words, 44 sources) unlocks for $0.20. Agents can pay with any x402 client; people can pay with a browser wallet.